Publication Ethics

Publication Ethics and Malpractice Statement

This journal follows guidelines from Committee on Publication Ethics (COPE) in facing all aspects of publication ethics and, in particular, how to handle cases of research and publication misconduct. All articles in this journal involving human subjects should respect principles of research ethics as described in Declaration of Helsinki and studies involving animals should obey the International Guiding Principles for Biomedical Research as developed by the Council for International Organization of Medical Sciences (CIOMS).

Pharmatech Journal adapts COPE to meet a high-quality standard of ethics for publisher, editors, authors, and reviewers. As an essential issue, publication ethics needs to be explained clearly to improve the quality of the research worldwide. In this part, we explain the standard for editors, authors, and reviewers. In addition, the publisher doesn’t have right to interfere with the integrity of the contents and only support to publish in a timely manner.

For Editors

  1. Editors should be responsible for every article published in Pharmatech Journal.
  2. Editors should help authors to follow the instruction for the author.
  3. The editors may communicate with other editors or reviewers in making the final decision.
  4. Editors has to evaluate the manuscript objectively for publication, judging each on its quality without looking to nationality, ethnicity, political beliefs, race, religion, gender, seniority, or institutional affiliation of the authors. He/she should decline his/her assignment when there is a potential for conflict of interest.
  5. Editors need to ensure the document sent to the reviewer does not contain the information of the author,.
  6. Editors  decision should be informed to authors accompanied by reviewers’ comments unless they contain offensive or libelous remarks.
  7. Editors should respect requests from authors that an individual should not review the submission if these are well-reasoned and practicable.
  8. Editors and all staffs should guarantee the confidentiality of the submitted manuscript.
  9. Editors will be guided by COPE flowcharts if there is a suspected misconduct or disputed authorship.

For Reviewers

  1. Reviewers  accepts the task from editor to review the scientific article and submit the review to the editor, in terms of determining the eligibility of the scientific article to be published.
  2. Reviewers commented on the possibility of errors in ethical research and publications.
  3. Reviewers will do the work in a timely manner and should notify the editor if they can not complete the work.
  4. Reviewers need to keep the confidentiality of the manuscript.
  5. Reviewers should not accept to review the manuscripts in which there is the potential conflict of interest between them and any of the authors.

For Authors

  1. Author(s) must make a statement that the article sent for publication is original, has not been published anywhere in any language, and is not in the process of being sent to other publishers.
  2. Author(s) should ensure the originality of the work and they have properly cited others’ work in accordance with the references format.
  3. Author(s) should not engage in plagiarism nor self-plagiarism.
  4. Author(s) must follow the criteria described in the guideline writing to the author of Pharmatech Journal
  5. Author(s)  are not advised to publish any personal information that may make the patient recognizable identity in the form of the description section, photograph or genealogy. When photographs of patients is very important and indispensable as scientific information, the authors have received approval in written form and has clearly stated it.
  6. In case of experimenting on human, the authors have certified that the process of the research is in accordance with ethical standards of Helsinki declaration, domestic and foreign committees that preside over human experi­ment. If any doubts are raised whether the research proceeded in accordance with the declaration, the authors should explain it. In case of experimenting on animals, the authors have certified that the authors had followed the domestic and foreign guideline related to experiment of animals in a laboratory.
  7. Author(s) should give the editor the data and details of the work if there are suspicions of data falsification or fabrication.
  8. Author(s) should clarify everything that may cause a conflict of interests such as work, research expenses, consul­tant expenses, and intellectual property on the document of form disclosure.